Biotie's VAP-1 antibody program to proceed to clinical studies in
rheumatoid arthritis and psoriasis patients
Biotie's VAP-1 antibody program to proceed to clinical studies in
rheumatoid arthritis and psoriasis patients<img src="http://feeds.foxbusiness.com/~r/foxbusiness/latest/~4/314421411" height="1" width="1"/><img src="http://feeds.foxnews.com/~r/foxnews/business/~4/314423637" height="1" width="1"/>
http://feeds.foxnews.com/~r/foxnews/business/~3/314423637/-503045316